EL7.AI
Stocks•23 June 2026•
1 min read

Jim Cramer Warns of Rising Competitive Threats to Intuitive Surgical's Market Dominance

Key Facts

1Jim Cramer expressed concerns about ISRG losing its dominant 'king' status in the robotic surgery market.
2Cramer highlighted major companies like J&J and Medtronic as emerging strong competitors in the sector.

Amid rapid shifts in the medical technology sector, serious concerns are emerging regarding the sustainability of operational dominance for industry leaders. Financial commentator Jim Cramer has expressed worries about Intuitive Surgical (ISRG) potentially losing its 'king' status in the robotic surgery market. According to reports, Cramer highlighted that the company is facing significant headwinds as powerful competitors with vast resources enter this critical field.

These warnings come as industry giants like Johnson & Johnson and Medtronic intensify their efforts to capture market share from the well-established 'da Vinci' system. Per market data, JNJ shares are trading at $235.30 (June 23, 2026), while MDT stood at $79.34 (June 18, 2026). Investors are closely watching how these peers might erode ISRG's margins by offering advanced technological alternatives at competitive price points.

Regarding price action, ISRG shares closed at $406.78 (close June 18, 2026), trading within a range of $400.93 to $409.64 during that session. Traders should watch for upcoming regulatory approvals for rival surgical systems and monitor broader US economic data; notably, retail sales rose 0.7% in June per the economic calendar, a factor that can influence overall healthcare capital expenditure sentiment.